Abstract Description
Finnerup will discuss how the new evidence support or may lead to changes in the therapeutic algorithm for neuropathic pain management. She will contextualise the new synthesis to the challenges with clinical trial design such as high placebo responses and responder analyses and direct comparison studies will also be discussed.
